Shares of the IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...

Shares of IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...

BTIG Life Sciences and Diagnostic Tools Analyst Massaro holds group dinner meeting with CEO Stueland and CFO Feeley on January 13 at 10:30 am.

GeneDx , a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through understanding gene-disease relationships, ...

GeneDx Holdings (WGS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

CEO Katherine Stueland sold 18,006 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The ...

TD Cowen raised the firm’s price target on GeneDx (WGS) to $118 from $75 and keeps a Buy rating on the shares. The firm reviewed its financial ...

GeneDx (NASDAQ: WGS) shares fell Wednesday. The company, a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the ...

(RTTNews) - GeneDx (WGS), Thursday announced the appointment of Bryan Dechairo as Chief Operating Officer, effective immediately. In the newly created role, Bryan will report to Katherine Stueland ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Bryan Dechairo as Chief Operating Officer, effective immediately.

GeneDx has appointed Bryan Dechairo as chief operating officer, effective immediately. The role is newly created, said the Stamford, Conn.-based genetic testing company. Dechairo will manage product ...